Introduction

Macroglossia and neurofibromatosis are two distinct medical conditions that, despite their differences, significantly impact an individual’s health and quality of life. Macroglossia refers to an abnormally large tongue, while neurofibromatosis is a genetic disorder causing tumours to form on nerve tissues

What is macroglossia?

Macroglossia is characterised by an enlarged tongue (painless) that can cause various complications, particularly affecting speech, chewing, swallowing and breathing.¹ Macroglossia is relatively rare, with congenital forms being more common in certain syndromes like Down syndrome.

Causes of macroglossia

Congenital conditions

• Down syndrome: a genetic disorder caused by an extra chromosome 21, where macroglossia is a common feature
• Beckwith-Wiedemann syndrome: a growth disorder syndrome synonymous with large body size, large organs, and other symptoms
• Congenital hypothyroidism: in this disorder, the thyroid gland does not make enough thyroid hormone at birth

Acquired conditions

• Amyloidosis: a condition where abnormal protein deposits accumulate in tissues and organs
• Acromegaly: a hormonal disorder that results from excess growth hormone, leading to enlarged body parts
• Tumors: Certain benign or malignant growths can lead to tongue enlargement

Symptoms of macroglossia

• Difficulty speaking, chewing, and swallowing
• Airway blockage could cause obstructive sleep apnea
• Dental problems, including misalignment and crowding of teeth

Diagnosis of macroglossia

• Physical examination: measurement and visual inspection of the tongue
• Imaging Studies: MRI or CT scans to assess the extent and underlying causes of tongue enlargement
• Biopsy: in cases where amyloidosis or tumours are suspected, a biopsy might be necessary

Treatment of macroglossia

• Medical Management: treating the underlying causes, such as thyroid hormone replacement in hypothyroidism or managing amyloidosis
• Surgical Intervention: in severe cases, a reduction glossoplasty (surgical reduction of tongue size) may be necessary to improve function and appearance

What is neurofibromatosis?

Neurofibromatosis is a genetically predisposed condition causing tumours on nerve tissues. It primarily exists in three forms: NF1, NF2 and schwannomatosis.² Neurofibromatosis type 1 (NF1) occurs in about 1 in 3,000 births, making it one of the most common genetic disorders. It is an autosomal dominant disorder, meaning only one parent needs a copy of the gene for offspring to be affected.³ NF2 is rare, it affects around 1 in 25,000-40,000 births.⁴ Schwannomatosis is less well understood but is estimated to affect about 1 in 40,000 people.⁵

Causes of neurofibromatosis

• NF1: Caused by mutations in the NF1 gene on chromosome 17, which produces a protein called neurofibromin
• NF2: Results from mutations in the NF2 gene on chromosome 22, affecting the production of merlin, another tumour suppressor protein
• Schwannomatosis: Involves mutations in the SMARCB1 or LZTR1 genes

Symptoms of neurofibromatosis

• NF1: Café-au-lait spots (see image below), Lisch nodules (benign growths on the iris), neurofibromas (skin tumours), and skeletal abnormalities
• NF2: Bilateral vestibular schwannomas leading to hearing loss, balance issues, and cataracts
• Schwannomatosis: Chronic pain due to schwannomas, but without the vestibular tumours seen in NF2

Diagnosis of neurofibromatosis

• Clinical criteria: based on physical symptoms and family history
• Genetic testing: this test will identify the genes involved
• Imaging Studies: MRI scan to detect tumours on nerves

Treatment of neurofibromatosis

• Medical management: pain management, physical therapy, and monitoring for complications such as malignant transformation
• Surgical intervention: removal of symptomatic tumours, especially in NF2 where vestibular schwannomas can affect hearing and balance
• Targeted therapies: emerging treatments targeting specific genetic pathways involved in tumour growth

What is the link between macroglossia and neurofibromatosis?

While macroglossia and neurofibromatosis are distinct conditions with different underlying causes and manifestations, there is a potential link between them, particularly in certain genetic disorders and syndromes.

Genetic syndromes linking macroglossia and neurofibromatosis

Genetic predisposition

Both macroglossia and neurofibromatosis can be associated with genetic mutations and hereditary conditions. This genetic link suggests that individuals with certain genetic syndromes might exhibit features of both conditions.

Common syndromes

Beckwith-wiedemann syndrome (BWS)

• Description: BWS is a growth disorder syndrome characterized by an increased risk of childhood cancer and certain congenital features, including macroglossia.
• Connection to neurofibromatosis: while not directly associated with neurofibromatosis, BWS involves genetic mutations that can also predispose individuals to other genetic conditions.

Noonan syndrome

• Description: Noonan syndrome is a genetic disorder that causes abnormal development in various parts of the body. Common features include unusual facial characteristics, short stature, heart defects, and other physical problems
• Connection to neurofibromatosis: some individuals with Noonan syndrome may also present with neurofibromatosis type 1 (NF1) due to overlapping genetic mutations involving the RAS-MAPK signalling pathway (a signalling pathway involving numerous genes in the cell, which is often implicated in cancer) 

Clinical overlap and manifestations

Tumor growth and enlargement

Both conditions involve abnormal tissue growth. In macroglossia, the tongue is enlarged, potentially due to the overgrowth of tissue. In neurofibromatosis, tumours (neurofibromas) grow on nerves throughout the body.

Individuals with neurofibromatosis, particularly NF1, can develop neurofibromas in various locations, including the head and neck region. This tumour growth could theoretically contribute to macroglossia if neurofibromas develop in the tongue or surrounding structures.

Functional impacts

Speech and swallowing

Macroglossia can cause difficulties in speech and swallowing due to the physical obstruction of an enlarged tongue. Similarly, neurofibromas in the oral and pharyngeal regions can interfere with these functions.

Respiratory issues

Both conditions can lead to obstructive sleep apnea; macroglossia by physically blocking the airway and neurofibromatosis by causing structural abnormalities that affect breathing during sleep.

Diagnosis and management overlap

Comprehensive genetic evaluation

Given the genetic nature of both conditions, individuals presenting with features of either macroglossia or neurofibromatosis may benefit from a comprehensive genetic evaluation. Identifying specific genetic mutations can help in diagnosing any overlapping syndromes and tailoring appropriate management strategies.

Multidisciplinary approach

Management of both conditions often requires a multidisciplinary approach, involving geneticists, paediatricians, neurologists, ENT specialists, and surgeons.

• Surgical interventions: surgery may be necessary for macroglossia to reduce tongue size, improve function, and enhance appearance. Similarly, surgical removal of neurofibromas may be needed to relieve symptoms and prevent complications
• Monitoring and follow-up: regular monitoring is crucial in both conditions to manage symptoms, monitor growth, and prevent complications

Quality of life and prognosis

Macroglossia

• Quality of Life: the impact on quality of life depends on the severity and underlying cause. Severe cases can interfere with daily activities, speech, and social interactions
• Prognosis: many congenital forms of macroglossia, like those associated with Down syndrome, can be managed effectively with surgical and medical treatments, leading to improved function and quality of life

Neurofibromatosis

• Quality of Life: neurofibromatosis significantly affects the quality of life due to chronic pain, cosmetic concerns, and neurological complications. Monitoring regularly with the appropriate medical care is vital
• Prognosis: NF1 and NF2 are lifelong conditions requiring ongoing management. The prognosis can vary widely based on the severity of symptoms and the presence of complications. Early detection and treatment of tumours are essential to prevent serious health issues

Summary

Macroglossia and neurofibromatosis are complex conditions that require a multidisciplinary approach for effective management. While macroglossia primarily affects the oral cavity and can often be surgically corrected, neurofibromatosis involves a broader spectrum of systemic symptoms due to its genetic nature. Understanding the causes, symptoms, diagnosis, and treatment options for both conditions is essential for providing optimal care and improving the quality of life for affected individuals. Macroglossia and neurofibromatosis, while distinct conditions, can be interconnected through genetic syndromes and overlapping clinical features. Understanding the genetic links and manifestations of both conditions allows for better diagnosis, management, and treatment strategies. A multidisciplinary approach and comprehensive genetic evaluation are essential in providing optimal care and improving the quality of life for individuals affected by these conditions. Advances in genetic research and medical treatments continue to enhance our understanding and management of these complex disorders.